Kathy Davy, VP of Virology and infectious diseases and Andy Worlock, Senior Director of Development
discuss Hologic’s legacy in virology and the viral load program.
The Aptima HIV-1 Quant Dx assay uses proprietary technology from Hologic—real-time transcription mediated amplification (TMA)—to offer excellent sensitivity and specificity.
TMA is the same technology that delivers the high standards of specificity for blood screening products.
TMA utilizes biochemical reactions, rather than mechanical thermocycling, to drive amplification.